Epigenetic and Developmental Regulation of Mammalian Genes

哺乳动物基因的表观遗传和发育调控

基本信息

项目摘要

The Ldb1 complex, including GATA-1 and TAL1, mediates long range interaction between the beta-globin locus control region (LCR) and gene in adult mouse erythroid cells. In an adult human erythroid cell model in which fetal gamma-globin genes can be robustly re-activated by cytokines, we showed that the Ldb1 complex mediates gamma-globin/LCR proximity through a site 3-prime to the genes. Reactivation of these genes may be therapeutically useful in beta-thalassemia and sickle cell disease and understanding how they are silenced is critical. Previous work in the lab showed that when Eto2, a co-repressor, associates with the Ldb1 complex, gamma-globin expression and LCR interactions are decreased. To identify factors functioning downstream of Eto2 that may regulate switching from gamma to beta-globin transcription, we performed RNA-Seq in control and Eto2 depleted K562 cells revealing over 1000 genes (Padj <0.05) mis-regulated in the absence of Eto2 that are now under study. To determine if Eto2 is required for hemoglobin switching, we established a model of this process in CD34+ umbilical cord blood cells and found that reduction of Eto2 using shRNA resulted in higher levels of gamma globin mRNA and a 2 day delay in the switch to predominant expression of beta globin compared to mock treated controls. In CD34+ bone marrow progenitor cells that normally express high levels of beta globin and low levels of gamma globin, reduction of Eto2 lead to predominant gamma globin expression. We are identifying direct targets of Eto2 using ChIP-Seq to clarify the pathways and genetic interactions mediated by Eto2. In addition, we are generating Eto2 null mice carrying a human beta-globin transgene to determine how Eto2 regulates expression of human beta globin genes in vivo. In other experiments, we are addressing the hypothesis that Eto2 regulates erythropoiesis. To determine the role of Eto2 in erythrocyte development, we analyzed expression of candidate genes in yolk sac from WT and Eto2-/- mouse embryos at 8.5 and 10.5 dpc and fetal liver at 12.5 and 15.5 dpc, the primary sites of erythropoiesis during these stages in development. The data suggest an overall defect in erythropoiesis. We have begun flow cytometric sorting experiments to address the stage in which erythroid development becomes impaired. Bgl3, a non-coding RNA transcript located downstream of the A-gamma globin gene, harbors an Ldb1 site that is involved in LCR looping. Bgl3 transcription parallels that of the gamma-globin in various erythroid cell models, although at a much lower level. To investigate the role of Bgl3 during hemoglobin switching we are following Bgl3 and gamma-globin transcripts by RT-PCR and RNA-FISH. To characterize the Bgl3 gene and to rule out the possibility of Bgl3 being a read-through transcript of the A-gamma globin gene located 3 kb upstream of the known Bgl3 gene sequence, we mapped the 5-prime end of Bgl3 by RACE and RT-PCR. We determined that the 5-prime end of Bgl3 is located 600 bp upstream of the sequence deposited in GenBank and also that Bgl3 and the A-gamma globin gene produce independent transcripts. In addition, to investigate whether the expression of gamma-globin depends on Bgl3 transcripts or its transcription per se, we knocked down and over-expressed Bgl3. We found that expression of gamma globin correlates with the levels of Bgl3. Also, we are examining the effect of manipulating Bgl3 levels on gamma globin long range LCR interactions. As Ldb1 and other erythroid specific transcription factors and the gamma globin gene repressor Bcl11a bind within the Bgl3 gene, we are studying if the Bgl3 locus could act as an enhancer. In Chip experiments we observed that this locus is occupied by the enhancer-specific transcription factor p300 and also it is marked by histone modifications associated with enhancers such as histone H3 K27 acetylation and histone H3 K4 mono methylation. Further, the ratio of H3 K4me1/H3 K4me3 is high which indicates the presence of an enhancer. To further investigate the potential enhancer function of Bgl3 we are performing luciferase reporter assays to quantitatively measure the expression of a reporter gene driven by a gamma globin gene promoter. We are also targeting deletion of Bgl3 sequences by genome editing and investigating its RNA-protein interactome. We are using homologous recombination in mouse ES cells study how individual globin genes establish stage specific enhancer communication. We targeted a region upstream of the mouse embryonic epsilon y gene on one allele in ES cells by homologous recombination. Recombinase mediated cassette exchange (RMCE) was used to insert chromatin insulator human HS5 or a transcription terminator in this position. In differentiating ES cells, insertion of the transcription terminator or hHS5 between the LCR and downstream genes inhibits embryonic ey gene activation in an allele-specific fashion but neither insertion affects expression of the downstream adult beta-globin gene. We have undertaken blastocyst injection of our successfully targeted ES cells. Recently we obtained mouse lines which carry the chromatin insulator or transcription terminator upstream of ey. Analyzing &#946; globin gene expression from embryonic peripheral blood or fetal liver at different developmental stages showed insertion of the chromatin insulator or transcription terminator disturbed embryonic globin gene activation only. For further investigation, we monitored intergenic transcription between the LCR and ey in WT mice and mice with the insulator or transcription terminator insertion. Presently, we are investigating RNA pol II localization across this region and at globin gene promoters using in vivo samples from WT and mutant mouse lines. Concurrently, we have introduced a mutant transcription terminator at the target position by homologous recombination to investigate as a control. Similar experiments are ongoing to introduce the insulator/transcription terminator at an additional target site that we have created between the embryonic and adult globin genes. Results from these mouse lines we are producing will be used to understand how long range interactions regulate beta-globin gene activation in a stage specific manner in vivo.
Ldb1复合体,包括GATA-1和TAL1,在成年小鼠红细胞中介导β -珠蛋白基因座控制区(LCR)和基因之间的远距离相互作用。在成人红细胞模型中,胎儿γ -珠蛋白基因可以被细胞因子强烈地重新激活,我们发现Ldb1复合物通过基因的3-prime位点介导γ -珠蛋白/LCR接近。这些基因的再激活可能在治疗-地中海贫血和镰状细胞病方面有用,了解它们是如何沉默的至关重要。先前的实验室研究表明,当协同抑制因子Eto2与Ldb1复合物结合时,γ -珠蛋白表达和LCR相互作用降低。为了确定Eto2下游可能调节γ -珠蛋白转录转换的因子,我们在对照和Eto2缺失的K562细胞中进行了RNA-Seq,发现超过1000个基因(Padj <0.05)在缺乏Eto2的情况下被错误调控,目前正在研究中。为了确定血红蛋白转换是否需要Eto2,我们在CD34+脐带血细胞中建立了这一过程的模型,发现使用shRNA减少Eto2导致γ -珠蛋白mRNA水平升高,与模拟处理的对照组相比,β -珠蛋白的主要表达转换延迟了2天。在CD34+骨髓祖细胞中,通常表达高水平的β -珠蛋白和低水平的γ -珠蛋白,Eto2的减少导致主要的γ -珠蛋白表达。我们正在使用ChIP-Seq识别Eto2的直接靶点,以阐明由Eto2介导的途径和遗传相互作用。此外,我们正在培养携带人类β -珠蛋白转基因的Eto2缺失小鼠,以确定Eto2如何在体内调节人类β -珠蛋白基因的表达。在其他实验中,我们正在解决Eto2调节红细胞生成的假设。为了确定Eto2在红细胞发育中的作用,我们分析了WT和Eto2-/-小鼠胚胎在8.5和10.5 dpc的卵黄囊以及12.5和15.5 dpc的胎儿肝脏中候选基因的表达,这是这些发育阶段红细胞生成的主要位点。这些数据提示红细胞生成的整体缺陷。我们已经开始流式细胞分选实验,以解决红系发育受损的阶段。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ann Dean其他文献

Ann Dean的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ann Dean', 18)}}的其他基金

CHROMATIN STRUCTURE IN REGULATION OF MAMMALIAN GENE EXPRESSION
哺乳动物基因表达调节中的染色质结构
  • 批准号:
    2572776
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Chromatin Structure In Regulation Of Mammalian Gene Expr
哺乳动物基因表达调控中的染色质结构
  • 批准号:
    7334688
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Chromatin Structure In Regulation Of Mammalian Gene Expr
哺乳动物基因表达调控中的染色质结构
  • 批准号:
    6983615
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Epigenetic and Developmental Regulation of Mammalian Genes
哺乳动物基因的表观遗传和发育调控
  • 批准号:
    7967839
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Epigenetics of developmental regulation of mammalian genes
哺乳动物基因发育调控的表观遗传学
  • 批准号:
    7593429
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
CHROMATIN STRUCTURE IN REGULATION OF MAMMALIAN GENE EXPRESSION
哺乳动物基因表达调节中的染色质结构
  • 批准号:
    6161891
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Chromatin Structure In Regulation Of Gene Expression
基因表达调控中的染色质结构
  • 批准号:
    6809848
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Epigenetic and Developmental Regulation of Mammalian Genes
哺乳动物基因的表观遗传和发育调控
  • 批准号:
    8553631
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Chromatin Structure in Regulation of Mammalian Gene Expression
哺乳动物基因表达调节中的染色质结构
  • 批准号:
    8939493
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:
Chromatin Structure in Regulation of Mammalian Gene Expression
哺乳动物基因表达调节中的染色质结构
  • 批准号:
    9553219
  • 财政年份:
  • 资助金额:
    $ 77.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了